BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 8923468)

  • 21. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
    Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for Grb2-associated binder-1 in growth hormone signaling.
    Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
    Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
    Ram PA; Waxman DJ
    J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization.
    Zhang Y; Jiang J; Kopchick JJ; Frank SJ
    J Biol Chem; 1999 Nov; 274(46):33072-84. PubMed ID: 10551877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
    VanderKuur JA; Wang X; Zhang L; Campbell GS; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1994 Aug; 269(34):21709-17. PubMed ID: 8063815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling.
    He K; Wang X; Jiang J; Guan R; Bernstein KE; Sayeski PP; Frank SJ
    Mol Endocrinol; 2003 Nov; 17(11):2211-27. PubMed ID: 12920237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
    Rui L; Gunter DR; Herrington J; Carter-Su C
    Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.
    Frank SJ; Yi W; Zhao Y; Goldsmith JF; Gilliland G; Jiang J; Sakai I; Kraft AS
    J Biol Chem; 1995 Jun; 270(24):14776-85. PubMed ID: 7540178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway.
    Ji S; Guan R; Frank SJ; Messina JL
    J Biol Chem; 1999 May; 274(19):13434-42. PubMed ID: 10224108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1999 Feb; 13(2):213-27. PubMed ID: 9973252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.
    Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
    Stofega MR; Argetsinger LS; Wang H; Ullrich A; Carter-Su C
    J Biol Chem; 2000 Sep; 275(36):28222-9. PubMed ID: 10842184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor.
    Xu BC; Wang X; Darus CJ; Kopchick JJ
    J Biol Chem; 1996 Aug; 271(33):19768-73. PubMed ID: 8702683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of Jak2 and Stat proteins.
    Hackett RH; Wang YD; Larner AC
    J Biol Chem; 1995 Sep; 270(36):21326-30. PubMed ID: 7673169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A beta-turn endocytic code is required for optimal internalization of the growth hormone receptor but not for alpha-adaptin association.
    Vleurick L; Pezet A; Kühn ER; Decuypere E; Edery M
    Mol Endocrinol; 1999 Nov; 13(11):1823-31. PubMed ID: 10551776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
    Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
    Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.